These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 22935826

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS, Lee YH, Chang YL.
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S, Liu JC, Kim D, Datti A, Zacksenhaus E.
    Breast Cancer Res; 2016 Jan 19; 18(1):9. PubMed ID: 26781438
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.
    Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY.
    Mod Pathol; 2017 Aug 19; 30(8):1086-1099. PubMed ID: 28548128
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?
    Projetti F, Lacroix-Triki M, Serrano E, Vergez S, Barres BH, Meilleroux J, Delisle MB, Uro-Coste E.
    J Oral Pathol Med; 2015 Apr 19; 44(4):244-51. PubMed ID: 25040635
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. miRNA-135b Contributes to Triple Negative Breast Cancer Molecular Heterogeneity: Different Expression Profile in Basal-like Versus non-Basal-like Phenotypes.
    Uva P, Cossu-Rocca P, Loi F, Pira G, Murgia L, Orrù S, Floris M, Muroni MR, Sanges F, Carru C, Angius A, De Miglio MR.
    Int J Med Sci; 2018 Apr 19; 15(6):536-548. PubMed ID: 29725243
    [Abstract] [Full Text] [Related]

  • 35. c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.
    Ren X, Yuan L, Shen S, Wu H, Lu J, Liang Z.
    Tumour Biol; 2016 Aug 19; 37(8):11385-95. PubMed ID: 26968553
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. MYB expression by immunohistochemistry is highly specific and sensitive for detection of solid variant of adenoid cystic carcinoma of the breast among all triple-negative breast cancers.
    Batra H, Bose PSC, Ding Y, Dai A, Chen H, Albarracin CT, Sun H, Sahin AA, Yang F, Wistuba II, Raso MG.
    Histopathology; 2024 Sep 19; 85(3):503-509. PubMed ID: 38973399
    [Abstract] [Full Text] [Related]

  • 39. Differential expression of epithelial cell adhesion molecule in salivary gland neoplasms.
    Phattarataratip E, Masorn M, Jarupoonphol W, Supatthanayut S, Saeoweiang P.
    Ann Diagn Pathol; 2016 Oct 19; 24():62-7. PubMed ID: 27649957
    [Abstract] [Full Text] [Related]

  • 40. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
    Nassar A, Sussman ZM, Lawson D, Cohen C.
    Breast J; 2012 Sep 19; 18(5):399-405. PubMed ID: 22882580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.